SkinMedica
Physician-dispensed American skincare built on growth-factor technology — the TNS serums are what plastic surgeons actually prescribe post-procedure.
Ask ChokChok AI
Get instant answers about SkinMedica
Try asking
SkinMedica is the US physician-dispensed brand responsible for mainstreaming growth-factor serums. The TNS Advanced+ Serum — derived from human fibroblast growth factors — is the most-prescribed post-procedure recovery serum in US cosmetic dermatology for a reason. Clinical-grade, eye-watering pricing, genuinely-documented efficacy for photoaged skin. Not for everyone — but for the "I'm four weeks post-Fraxel and need recovery" use case, nothing beats it.
Strengths
- + growth-factor technology with real published data
- + TNS Advanced+ is the US post-procedure gold standard
- + Allergan-owned — serious regulatory discipline
- + physician-channel gatekeeping means fewer counterfeits
Weaknesses
- − premium pricing ($295+ for flagship serum)
- − growth-factor sourcing raises ethical questions for some buyers (human fibroblast-derived)
- − pregnancy-safety debated — most OBGYNs advise against
- − distribution is tightly physician-channel-only
The SkinMedica Story
SkinMedica was founded in 1999 in Carlsbad, California, by the team that first isolated and patented TNS (Tissue Nutrient Solution) — a proprietary blend of growth factors, cytokines, and matrix proteins derived from human fibroblast conditioned media. The TNS Essential Serum launched in 2001 as the first commercial growth-factor topical; TNS Advanced+ (2019) is the current flagship, combining the original TNS stack with peptides and antioxidants. Acquired by Allergan (now AbbVie) in 2012, the brand remains physician-dispensed only in the US, making counterfeits rare and the brand's reputation tightly controlled. The TNS serums are what post-procedure patients are actively prescribed across American cosmetic dermatology — the category's 25-year benchmark.
All SkinMedica Products
4 products reviewed and rated.
TNS Advanced+ Serum
The US cosmetic-derm world's post-procedure gold standard. TNS — Tissue Nutrient Solution, a growth-factor complex derived from human fibroblast conditioned media — paired with signal peptides and barrier support. Clinical data on photoaging is published and serious. $295 is genuinely expensive, but the 4–6 week post-Fraxel case is exactly what this product was built for.
Lytera 2.0 Pigment Correcting Serum
SkinMedica's Lytera 2.0 is the physician-dispensed depigmentation serum — tranexamic acid (plasminogen activation inhibition), niacinamide (melanosome transfer inhibition), phenylethyl resorcinol (tyrosinase inhibition), and tetrapeptide-30 (melanocyte signalling modulation). Four mechanisms targeting pigmentation at four different stages. Allergan's physician-channel brand delivers the multi-mechanism approach dermatologists wish prescription hydroquinone offered.
Compare SkinMedica With
Similar US-Beauty brands
Brands with comparable formulation chops and price points
